Balyasny Asset Management LLC Neuronetics, Inc. Transaction History
Balyasny Asset Management LLC
- $57.8 Billion
- Q1 2025
A detailed history of Balyasny Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,417,051 shares of STIM stock, worth $5.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,417,051
Previous 1,481,771
4.37%
Holding current value
$5.7 Million
Previous $2.21 Million
136.25%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding STIM
# of Institutions
109Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$9.27 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.99 Million1.44% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.42 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.02 Million0.19% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$3.7 Million1.7% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $109M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...